Stereotaxis, Inc. (STXS) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
STXS currently has 98.9M outstanding shares. with significant dilution risk as 274M authorized shares could dilute existing holders by 277.4%. The company has diluted shareholders by 19.27% over the past 2 years through share issuances.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 13, 2026 |
10-Q filing | 98.9M shares outstanding |
99M | 270M |
| Mar 13, 2026 |
S-3 filing: This S-3 filing indicates that the company may offer and sell up to $100,000,000 in the aggregate of debt securities, common stock, preferred stock, warrants, rights or units consisting of any two or more of such securities via a shelf registration. |
97M | 270M |
| Mar 12, 2026 |
10-K filing | 91.0M shares outstanding |
91M | 190M |
| Nov 12, 2025 |
10-Q filing | 92.0M shares outstanding |
92M | 190M |
| Jul 17, 2025 |
8-K filing: Stereotaxis, Inc. entered into a placement agency agreement with Lake Street Capital Markets, LLC and a securities purchase agreement with certain investors to sell $12.5 million shares of common stock in a registered direct offering. ($12.5M proceeds) |
88M | 190M |
| May 13, 2025 |
10-Q filing | 87.8M shares outstanding |
88M | 190M |
| Mar 14, 2025 |
10-K filing | 85.2M shares outstanding |
85M | 190M |
| Nov 14, 2024 |
10-Q filing | 85.8M shares outstanding |
86M | 190M |
| Sep 06, 2024 |
S-3/A filing: This S-3/A filing relates to the resale of up to 6,100,000 shares of common stock by the Selling Stockholder, APT Holding Company, Inc., acquired in connection with the acquisition of Access Point Technologies EP, Inc. |
85M | 190M |
| Aug 23, 2024 |
S-3 filing: This S-3 filing relates to the resale of up to 6,100,000 shares of common stock by the selling stockholder, APT Holding Company, Inc., acquired in connection with the acquisition of Access Point Technologies EP, Inc. |
85M | 190M |
| Aug 14, 2024 |
10-Q filing | 84.6M shares outstanding |
85M | 190M |
| Aug 02, 2024 |
8-K filing: Stereotaxis, Inc. completed the acquisition of Access Point Technologies EP, Inc. and issued 1,486,620 shares of its common stock as Upfront Stock Consideration on July 31, 2024. |
83M | 190M |
| May 16, 2024 |
8-K filing: Stereotaxis, Inc. entered into a Share Purchase Agreement with APT Holding Company, Inc. to acquire all equity interests of Access Point Technologies EP, Inc., paying upfront consideration of Stereotaxis common stock subject to closing conditions and a negative net working capital adjustment, as well as additional stock consideration pursuant to earnout provisions. |
83M | 190M |
| May 15, 2024 |
10-Q filing | 83.5M shares outstanding |
83M | 190M |
| Mar 08, 2024 |
10-K filing | 80.7M shares outstanding |
81M | 190M |
| Nov 13, 2023 |
10-Q filing | 82.5M shares outstanding |
82M | 190M |
| Aug 11, 2023 |
10-Q filing | 81.0M shares outstanding |
81M | 190M |
| Jun 01, 2023 |
S-3/A filing: The prospectus included in the S-3 Registration Statement is a combined prospectus which relates to (i) the Registration Statement on Form S-1 (File No. 333-214255) relating to an aggregate of 86,065,014 shares of the registrant's common stock and (ii) the registration of 10,000,000 additional shares of the registrant's common stock for resale by the selling stockholders as set forth in the S-3 Registration Statement. |
77M | 190M |
| May 19, 2023 |
S-3 filing: The company is filing an S-3 shelf registration to offer and sell up to $100,000,000 in the aggregate of debt securities, common stock, preferred stock, warrants, rights or units consisting of any two or more of such securities from time to time. |
77M | 180M |
| May 19, 2023 |
S-3 filing: This prospectus relates to the offer, resale or other disposition of up to an aggregate of 91,221,439 shares of our common stock, comprised of (i) up to 54,921,439 shares issuable upon the conversion of our Series A Convertible Preferred Stock and (ii) 36,300,000 shares of common stock upon exercise of certain related warrants, in each case held by the selling stockholders named in this prospectus or their transferees. |
77M | 180M |
| May 12, 2023 |
10-Q filing | 76.5M shares outstanding |
77M | 33M |
| Mar 09, 2023 |
10-K filing | 76.1M shares outstanding |
76M | 33M |
| Nov 14, 2022 |
10-Q filing | 76.1M shares outstanding |
76M | 33M |
| Aug 11, 2022 |
10-Q filing | 76.0M shares outstanding |
76M | 33M |
| May 11, 2022 |
10-Q filing | 75.9M shares outstanding |
76M | 33M |
| Mar 10, 2022 |
10-K filing | 75.6M shares outstanding |
76M | 33M |
| Nov 12, 2021 |
10-Q filing | 75.7M shares outstanding |
76M | 33M |
| Aug 12, 2021 |
10-Q filing | 75.5M shares outstanding |
76M | 33M |
| May 13, 2021 |
10-Q filing | 75.2M shares outstanding |
75M | 33M |
| Mar 12, 2021 |
10-K filing | 72.7M shares outstanding |
73M | 33M |
| Nov 09, 2020 |
10-Q filing | 74.5M shares outstanding |
74M | 33M |
| Aug 06, 2020 |
10-Q filing | 71.6M shares outstanding |
72M | 33M |
| May 26, 2020 |
8-K filing: Stereotaxis, Inc. entered into a Securities Purchase Agreement with Consonance Capital Opportunity Master Fund, LP and P Consonance Opportunities Ltd. for the registered offering of 3,658,537 shares of the Company's common stock at a price of $4.10 per share, resulting in approximately $15 million of gross proceeds to the Company. ($15.0M proceeds) |
59M | 33M |
| May 11, 2020 |
10-Q filing | 59.1M shares outstanding |
59M | 33M |
| Mar 16, 2020 |
10-K filing | 22.8M shares outstanding |
23M | 33M |
| Mar 16, 2020 |
S-3 filing: The company is filing a shelf registration statement for the potential sale of up to $100,000,000 in debt securities, common stock, preferred stock, warrants, rights, or units. |
N/A | 33M |